Skip to main content
Top
Published in: Clinical Rheumatology 9/2011

01-09-2011 | Brief Report

Hybrid 18F-FDG PET–MRI of the hand in rheumatoid arthritis: initial results

Authors: Falk Miese, Axel Scherer, Benedikt Ostendorf, Alexander Heinzel, Rotem S. Lanzman, Patric Kröpil, Dirk Blondin, Hubertus Hautzel, Hans-Jörg Wittsack, Matthias Schneider, Gerald Antoch, Hans Herzog, N. Jon Shah

Published in: Clinical Rheumatology | Issue 9/2011

Login to get access

Abstract

18F-fluorodeoxyglucose PET (18F-FDG PET) is highly sensitive to inflammatory changes within the synovial tissue in rheumatoid arthritis (RA). However, the highest spatial resolution for soft tissue can be achieved with MRI. Here, we report on the first true hybrid PET–MRI examination of the hand in early RA exploiting the advantages of both modalities. PET–MRI was performed with a prototype of an APD-based magneto-insensitive BrainPET detector (Siemens Healthcare, Erlangen, Germany) operated within a standard 3T MR scanner (MAGNETOM Trio, Siemens). PET images were normalized, random, attenuation and scatter-corrected, iteratively reconstructed and calibrated to yield standardized uptake values (SUV) of 18F-FDG uptake. T1-weighted TSE in coronal as well as sagittal orientation prior to and following Gadolinium administration were acquired. Increased 18F-FDG uptake was present in synovitis and tenovaginitis as identified on contrast-enhanced MRI. The tracer distribution was surrounding the metacarpophalangeal joints II and III. Maximum SUV of 3.1 was noted. In RA, true hybrid 18F-FDG PET–MRI of the hand is technically feasible and bears the potential to directly visualize inflammation.
Literature
1.
go back to reference Beckers C, Jeukens X, Ribbens C et al (2006) (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 33(3):275–280PubMedCrossRef Beckers C, Jeukens X, Ribbens C et al (2006) (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 33(3):275–280PubMedCrossRef
2.
go back to reference Brenner W (2004) 18F-FDG PET in rheumatoid arthritis: there still is a long way to go. J Nucl Med 45(6):927–929PubMed Brenner W (2004) 18F-FDG PET in rheumatoid arthritis: there still is a long way to go. J Nucl Med 45(6):927–929PubMed
3.
go back to reference Ostendorf B, Scherer A, Wirrwar A et al (2006) High-resolution multipinhole single-photon-emission computed tomography in experimental and human arthritis. Arthritis Rheum 54(4):1096–1104PubMedCrossRef Ostendorf B, Scherer A, Wirrwar A et al (2006) High-resolution multipinhole single-photon-emission computed tomography in experimental and human arthritis. Arthritis Rheum 54(4):1096–1104PubMedCrossRef
4.
go back to reference Chaudhari A, Bowen S, Burkett G et al (2010) High-resolution (18)F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis. Eur J Nucl Med Mol Imaging 37(5):1047PubMedCrossRef Chaudhari A, Bowen S, Burkett G et al (2010) High-resolution (18)F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis. Eur J Nucl Med Mol Imaging 37(5):1047PubMedCrossRef
5.
go back to reference Palmer W, Rosenthal D, Schoenberg O et al (1995) Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 196(3):647–655PubMed Palmer W, Rosenthal D, Schoenberg O et al (1995) Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 196(3):647–655PubMed
6.
go back to reference Roivainen A, Parkkola R, Yli-Kerttula T et al (2003) Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 48(11):3077–3084PubMedCrossRef Roivainen A, Parkkola R, Yli-Kerttula T et al (2003) Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 48(11):3077–3084PubMedCrossRef
7.
go back to reference Maruotti N, Crivellato E, Cantatore F, Vacca A, Ribatti D (2007) Mast cells in rheumatoid arthritis. Clin Rheumatol 26(1):1–4PubMedCrossRef Maruotti N, Crivellato E, Cantatore F, Vacca A, Ribatti D (2007) Mast cells in rheumatoid arthritis. Clin Rheumatol 26(1):1–4PubMedCrossRef
8.
go back to reference Maruotti N, Cantatore F, Crivellato E, Vacca A, Ribatti D (2006) Angiogenesis in rheumatoid arthritis. Histol Histopathol 21(5):557–566PubMed Maruotti N, Cantatore F, Crivellato E, Vacca A, Ribatti D (2006) Angiogenesis in rheumatoid arthritis. Histol Histopathol 21(5):557–566PubMed
10.
go back to reference Hautzel H, Sander O, Heinzel A, Schneider M, Müller H (2008) Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 49(7):1107–1113PubMedCrossRef Hautzel H, Sander O, Heinzel A, Schneider M, Müller H (2008) Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 49(7):1107–1113PubMedCrossRef
Metadata
Title
Hybrid 18F-FDG PET–MRI of the hand in rheumatoid arthritis: initial results
Authors
Falk Miese
Axel Scherer
Benedikt Ostendorf
Alexander Heinzel
Rotem S. Lanzman
Patric Kröpil
Dirk Blondin
Hubertus Hautzel
Hans-Jörg Wittsack
Matthias Schneider
Gerald Antoch
Hans Herzog
N. Jon Shah
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1777-3

Other articles of this Issue 9/2011

Clinical Rheumatology 9/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.